Global Indices
Global Indices 21-Apr Prev_Day Abs. Change
% Change
Russell 3000 2,101 2,082 19 0.90
Nasdaq 13,950 13,786 164 1.19
FTSE 6,895 6,860 35 0.52
Nikkei 28,509 29,100 -592 -2.03
Hang Seng 28,622 29,136 -514 -1.76
Indian Indices 20-Apr Prev_Day Abs. Change
% Change
S&P BSE Sensex 47,706 47,949 -244 -0.51
Nifty 50 14,296 14,359 -63 -0.44
Nifty 100 14,467 14,513 -46 -0.32
Nifty 500 12,055 12,076 -21 -0.17
Nifty Bank 31,113 31,208 -96 -0.31
S&P BSE Power 2,383 2,381 2 0.09
S&P BSE Small Cap 20,776 20,674 101 0.49
S&P BSE HC 23,387 23,106 281 1.22
Date P/E Div. Yield P/E Div. Yield
20-Apr 32.59 0.83 31.97 1.00
Month Ago 34.71 0.72 40.16 1.08
Year Ago 18.42 1.34 20.10 1.69
Nifty 50 Top 3 Gainers
Company 20-Apr Prev_Day
% Change
Dr.Reddy 5157 4968 3.80
Bajaj Finserv Limited 9819 9470 3.69
Bajaj Finance 4614 4480 2.99
Nifty 50 Top 3 Losers Domestic News
Company 20-Apr Prev_Day
% Change
Ultratech Cem 6201 6510 -4.75
HCL Tech 961 995 -3.35
HDFC Ltd. 2416 2492 -3.07
Advance Decline Ratio
BSE
NSE
[1]
Advances 1613 1073
Declines 1268 828
Unchanged 168 116
Institutional Flows (Equity)
Description (Cr)
YTD
FII Flows* 48700
MF Flows** -25755
*20
th
Apr 2021; **16
th
Apr 2021
Economic Indicator
YoY(%) Current Year Ago
CPI
IIP
GDP
0.40%
(Dec-20)
3.30%
(Dec-19)
[1]
Data as on 20 Apr, 2021
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
22 April 2021
Since May-17, MOSPI has revised base year of IIP & WPI from 2004-05 to 2011-12, and for CPI from
2010 to 2012
Indian Equity Market
Indices Performance
P/E Dividend Yield
Sensex Nifty
-1.60%
(Nov-20)
-7.50%
(Sep-20)
Quarter Ago
Inflow/Outflow
80
-1654
• Indian equity markets witnessed sharp sell off in the last trading hour as
incidents of localised lockdowns weighed on investor sentiments. The state
of Maharashtra tightened COVID-19-related curbs, allowing shops to stay
open only between 7 AM and 11 AM, while eastern state of Jharkhand
announced a complete lockdown for a week, starting Apr 21.
• Key benchmark indices S&P BSE Sensex and Nifty 50 lost 0.51% and 0.44%
to close at 47,705.80 and 14,296.40 respectively.
• The overall market breadth on BSE was strong with 1,613 scrips advancing
and 1,268 scrips declining. A total of 168 scrips remained unchanged.
• On the BSE sectoral front, S&P BSE Healthcare was the major gainer, up
1.22% followed by S&P BSE Auto, up 0.9% and S&P BSE Capital Goods, up
0.89%. S&P BSE IT was the major loser, down 1.05% followed by S&P BSE
Teck, down 0.77% and S&P BSE Basic Materials, down 0.73%.
• The Union Cabinet gave ex-post facto approval to the official amendments
to the Finance Bill, 2021, which were aimed at clarifying and rationalising
tax proposals for 2021-22. The changes were necessary to better explain
and rationalise the proposals, as well as to resolve stakeholders' concerns
about the proposals in the Finance Bill. The Finance Bill became the Finance
Act, 2021 on Mar 28, 2021 after receiving the President's nod.
• According to the Securities and Exchange Board of India (Sebi), investment
advisors may provide execution services to their advisory clients without
charging any commissions or fees. It also stated that an investment advisor
cannot receive any compensation from asset management companies
(AMCs) whose direct plans are offered to clients for the services provided
to them.
• As per media reports, the government is expected to waive the 10%
customs duty on imported vaccines in order to keep the cost of overseas
vaccines, which are being considered as a complement to domestically
produced vaccinations, low until the COVID-19 vaccination is made available
to all people over the age of 18.
• A major credit rating agency lowered its FY22 growth forecast by 0.5% on
the upper end, as a new wave of lockdowns and restrictions are placed in
pockets to combat the growing COVID-19 cases. The agency now expects
the economy to rise 10% to 10.5% in FY22, down from 10% to 11%
previously forecast.
• Nestle India reported 14.6% YoY rise in its net profit to Rs. 602 crore for the
quarter ended Mar 2021 as against Rs. 525 crore in the year-ago period.
Total sales increased 8.9% during the quarter, while domestic sales rose
10.2% mainly driven by volumes.
• Bharat Biotech has increased the manufacturing ability of its COVID-19
vaccine, Covaxin, to 700 million doses per year to support vaccination
campaigns in India and around the world.
• Asian markets closed in the red as a resurgence of coronavirus infections in
some countries cast doubt over an economic rebound from the pandemic.
Today (as on Apr 22), markets are trading higher following an overnight
bounce on Wall Street. Both Nikkei and Hang Seng are up 1.65% and 0.12%
(as at 8:00 AM IST), respectively.
• European markets went up, led by some encouraging corporate earnings
announcements and economic data.
• U.S. markets closed in the green with investors reluctant to sell stocks
despite higher valuation, amid worries about missing out on further upside.